Crescent Biopharma (CBIO) EBT Margin (2013 - 2026)
Crescent Biopharma's EBT Margin was -2240.90% in Q1 2026.
Powered by 
Analysis
Crescent Biopharma (CBIO) EBT Margin (2013 - 2026) Analysis & Trends
For FY2025, EBT Margin at Crescent Biopharma came in at -1401.16%, up 2879.87 percentage points from FY2024.
- EBT Margin shows a five-year change of -894.33 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was -4281.03% in FY2024 (+388471.90 pp), -392752.93% in FY2023 (-329548.50 pp), -63204.43% in FY2022 (-57733.74 pp) and -5470.69% in FY2021 (-4963.85 pp).
- The Q1 2026 figure marks the highest quarterly EBT Margin since Q4 2023.
- The best year-over-year quarter for EBT Margin over five years was Q2 2022 (a gain of 10126197.20 percentage points); the worst was Q1 2022 (a drop of 206032.93 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | Crescent Biopharma | 418.60 Mn | -288.70 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2,240.90% |
| Sep 30, 2024 | -6,088.12% |
| Jun 30, 2024 | -3,948.98% |
| Mar 31, 2024 | -2,937.69% |
| Dec 31, 2023 | -1,872.50% |
| Sep 30, 2023 | -1,606.19% |
| Jun 30, 2023 | -1,330.78% |
| Mar 31, 2023 | -1,880.97% |
| Jun 30, 2022 | -17,804.21% |
| Mar 31, 2022 | -207,385.91% |
| Dec 31, 2021 | -98,870.20% |
| Sep 30, 2021 | -20,028.82% |
| Jun 30, 2021 | -10,144,001.41% |
| Mar 31, 2021 | -1,352.98% |
| Dec 31, 2020 | -9,554.94% |
| Sep 30, 2020 | -1,372.73% |
| Mar 31, 2020 | -90.09% |
| Dec 31, 2019 | -2,518.94% |
| Dec 31, 2018 | -1,420.77% |
| Sep 30, 2016 | -42,631.11% |
API Access
Crescent Biopharma EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();